Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar;91(3):654-661.
doi: 10.1111/bcp.16152. Epub 2024 Jun 26.

Management of serotonin syndrome (toxicity)

[Article in French]
Affiliations
Review

Management of serotonin syndrome (toxicity)

[Article in French]
Angela L Chiew et al. Br J Clin Pharmacol. 2025 Mar.

Abstract

Serotonin syndrome (toxicity), resulting from an excessive accumulation of serotonin in the central nervous system, it can occur due to various factors such as the initiation of medication, overdose or drug interactions. Diagnosing serotonin toxicity presents challenges as there are no definitive criteria. This review delves into the pathophysiology, incidence, clinical assessment and management of serotonin toxicity, stressing the significance of promptly recognizing and managing severe cases. Diagnosis relies primarily relies on clinical assessment due to the absence of specific laboratory tests. The Hunter Serotonin Toxicity criteria are commonly utilized but have only been validated in the overdose setting. Assessing the severity of toxicity is crucial for guiding management decisions. Supportive care, discontinuation of causative agents and symptomatic treatment are prioritized in management. Mild toxicity often requires withdrawal or reduction of the serotonergic agent, while more severe toxicity requires more aggressive resuscitative and supportive care. Severe serotonin toxicity characterized by hyperthermia and rigidity requires aggressive supportive measures, including benzodiazepines, intubation, paralysis and active cooling. Animal studies suggest potential benefits of 5-HT2A receptor antagonists in preventing hyperthermia and fatalities, but only at high doses. Their clinical effectiveness remains uncertain, and evidence is predominately from case series and case reports. Although commonly used, serotonin antagonists like cyproheptadine lack conclusive evidence of efficacy. Other serotonin antagonists such as chlorpromazine and olanzapine have been explored but evidence is limited to case reports. Hence, the cornerstone of treating severe cases does not lie in 'antidote' administration or even diagnosis but in effective early resuscitative and supportive care.

Keywords: cyproheptadine; serotonin antagonist; serotonin syndrome; serotonin toxicity; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Spectrum of serotonin toxicity and its management., Figure created with BioRender.com.
FIGURE 2
FIGURE 2
Hunter Serotonin Toxicity Criteria. Flow diagram based on the Hunter Serotonin Toxicity criteria. Source: Figure reproduced with permission from Isbister et al. 2007.,

References

    1. Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors structure and function at the molecular level. Curr Top Med Chem. 2002;2(6):507‐528. doi: 10.2174/1568026023393796 - DOI - PubMed
    1. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60(1):355‐366. doi: 10.1146/annurev.med.60.042307.110802 - DOI - PMC - PubMed
    1. Saper C. Brainstem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles in Neural Science. 4th ed. McGraw‐Hill; 2000.
    1. Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions. Int J Tryptophan Res. 2019;12:1178646919873925. doi: 10.1177/1178646919873925 - DOI - PMC - PubMed
    1. Mignon L, Wolf WA. Postsynaptic 5‐HT(1A) receptors mediate an increase in locomotor activity in the monoamine‐depleted rat. Psychopharmacology (Berl). 2002;163(1):85‐94. doi: 10.1007/s00213-002-1121-3 - DOI - PubMed

MeSH terms

LinkOut - more resources